We examined protein and mRNA levels of CK2α, CK2α’, CK2β, and BCL-XL in a panel of myeloid leukemia cells, using Western blot (Figure 1A) and qRT-PCR, respectively (Figure 1B). This evidence concerns the gene BCL2L1 and myeloid leukemia.